67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy
source: pixabay.com

67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy

  A grandmother of four in Maryland has recently become the first cancer patient to complete the experimental CAR-T cell procedure at Georgetown University Hospital. Daisy Diggs 67, who was…

Continue Reading 67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy

Experimental Treatment for Macular Telangiectasia Type 2 Earns Fast Track Designation

According to a story from prnewswire.com, the biopharmaceutical company Neurotech Pharmaceuticals recently announced that the company had earned Fast Track designation from the US Food and Drug Administration (FDA). This…

Continue Reading Experimental Treatment for Macular Telangiectasia Type 2 Earns Fast Track Designation
Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits
allinonemovie / Pixabay

Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits

According to a story from BBC, Mats Steen passed away at 25 years old due to complications from his Duchenne muscular dystrophy. Upon his death, parents Robert and Trude grieved…

Continue Reading Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits

Upcoming FREE MDS Event in Florida!

Our partner, The MDS Foundation is sponsoring another free MDS Patient & Family/Caregiver Forum. This forum will take place in Jacksonville, Florida When: Saturday, March 30th, 2019 Where: Mayo Clinic Cancer…

Continue Reading Upcoming FREE MDS Event in Florida!
Experimental Cancer Drug Displays Potential in a Number of Rare Cancers
MALCOLUMBUS / Pixabay

Experimental Cancer Drug Displays Potential in a Number of Rare Cancers

According to a story from EurekAlert!, a new type of cancer drug that is being described as a "Trojan horse" that infiltrates cancer tumors is showing potential in several types…

Continue Reading Experimental Cancer Drug Displays Potential in a Number of Rare Cancers
International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy
Source: Pixabay

International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy

Hypoparathyroidism Hypoparathyroidism (HP) is caused by low levels of the parathyroid hormone (PTH). Most people develop this disease after thyroid surgery as a result of accidental damage/removal of the parathyroid…

Continue Reading International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy
Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?
stevepb / Pixabay

Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?

According to a story from Andre Eger, the drug developer Gilead recently had the misfortune to announce that its clinical trial testing an experimental drug for late stage nonalcoholic steatohepatitis…

Continue Reading Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?

Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

According to a study published in the Orphanet Journal of Rare Diseases, a study that was intended to identify a new approach to monitoring the progression of x-linked adrenoleukodystrophy in women…

Continue Reading Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

Sexual Abuse in Medical Research: How Can Justice be Served?

Content Warning: The following article discusses sexual abuse. According to a story from Buzzfeed News, many former patients of an esteemed medical researcher named Reginald Archibald, who was affiliated with…

Continue Reading Sexual Abuse in Medical Research: How Can Justice be Served?

New Treatment for GEP-NETs Approved in Canada

According to a story from pm360online.com, the Novartis company Advanced Accelerator Applications S.A. recently announced that Health Canada has issued approval for Lutathera™ as a treatment for gasteroenteropancreatic neuroendocrine tumors…

Continue Reading New Treatment for GEP-NETs Approved in Canada

Can Amyotrophic Lateral Sclerosis Patients Speak Again With New Technology?

The Importance of Speech The ability to speak gives individuals not only the opportunity to communicate with one another, it provides an outlet for expression, creativity, and connectedness. Unfortunately, that…

Continue Reading Can Amyotrophic Lateral Sclerosis Patients Speak Again With New Technology?

Bernie Sanders Fights Back Against 375,000 Price Tag for Lambert-Eaton Myasthenic Syndrome Treatment

Lambert-Eaton Myasthenic Syndrome Lambert-Eaton Myasthenic syndrome (LEMs) is a rare autoimmune disease. The body's immune system targets nerve cells meaning patients experience muscle weakness. Other symptoms of LEMs include difficulty walking…

Continue Reading Bernie Sanders Fights Back Against 375,000 Price Tag for Lambert-Eaton Myasthenic Syndrome Treatment
The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma
johnhain / Pixabay

The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma

According to a story from pm360online.com, The National Brain Tumor Society (NBTS) recently awarded $750,000 to the Global Coalition for Adaptive Research. This cash is slated to go towards the…

Continue Reading The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma